Itafos Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

ItafosDer Gewinn pro Aktie wird voraussichtlich um 74.6% pro Jahr wachsen.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

78.9%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	25.7%
Wachstumsrate der Einnahmen	n/a
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	None
Zuletzt aktualisiert	n/a

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

This Analyst Just Made A Massive Upgrade To Their Itafos (CVE:IFOS) Earnings Forecasts

Feb 18

Can You Imagine How Elated Itafos' (CVE:IFOS) Shareholders Feel About Its 743% Share Price Gain?

Dec 17

Gewinn- und Umsatzwachstumsprognosen

TSXV:IFOS - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2024	463	-5	41	104	N/A
3/31/2024	474	-1	38	95	N/A
12/31/2023	466	4	40	95	N/A
9/30/2023	482	81	69	112	N/A
6/30/2023	524	86	139	176	N/A
3/31/2023	563	110	138	174	N/A
12/31/2022	593	115	169	208	N/A
9/30/2022	575	109	163	198	N/A
6/30/2022	525	117	112	149	N/A
3/31/2022	473	82	97	134	N/A
12/31/2021	413	51	60	94	N/A
9/30/2021	372	17	38	68	N/A
6/30/2021	316	-12	29	53	N/A
3/31/2021	275	-43	5	19	N/A
12/31/2020	260	-63	-17	-3	N/A
9/30/2020	267	-141	-38	-10	N/A
6/30/2020	301	-148	-30	7	N/A
3/31/2020	342	-149	-23	21	N/A
12/31/2019	339	-144	-12	35	N/A
9/30/2019	359	-211	-16	35	N/A
6/30/2019	353	-204	-44	10	N/A
3/31/2019	317	-178	-58	2	N/A
12/31/2018	302	-113	-82	-19	N/A
9/30/2018	202	34	-79	-24	N/A
6/30/2018	125	39	-68	-20	N/A
3/31/2018	58	27	N/A	-36	N/A
12/31/2017	N/A	-30	N/A	-26	N/A
9/30/2017	N/A	-63	N/A	-28	N/A
6/30/2017	N/A	-101	N/A	-23	N/A
3/31/2017	N/A	-103	N/A	-16	N/A
12/31/2016	N/A	-101	N/A	-14	N/A
9/30/2016	N/A	-76	N/A	-7	N/A
6/30/2016	N/A	-75	N/A	-5	N/A
3/31/2016	N/A	-79	N/A	-4	N/A
12/31/2015	N/A	-118	N/A	-7	N/A
9/30/2015	N/A	-111	N/A	-4	N/A
6/30/2015	N/A	-84	N/A	-2	N/A
3/31/2015	N/A	-78	N/A	-3	N/A
12/31/2014	N/A	-29	N/A	3	N/A
9/30/2014	N/A	-31	N/A	28	N/A
6/30/2014	N/A	-18	N/A	16	N/A
3/31/2014	N/A	-29	N/A	18	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von IFOS über der Sparquote liegt (2.1%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von IFOS schneller wachsen werden als der Markt Canadian

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von IFOS in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von IFOS schneller wachsen werden als der Markt von Canadian.

Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von IFOS schneller wachsen werden als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von IFOS in 3 Jahren voraussichtlich hoch sein wird

Itafos Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Itafos Inc. Maintains Operating Guidance for the Year 2024

Itafos Inc. Narrows its Earnings Guidance for 2023

Itafos Inc. Provides Earnings Guidance for the Year 2023

Consensus EPS estimates increase by 16%

Consensus EPS estimates fall by 26%

Price target decreased to CA$5.25

Recent updates

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Maintains Operating Guidance for the Year 2024

Niobium Dragon Pty Ltd entered into a binding Share Sale Agreement to acquire Itafos Arraias Mineração e Fertilizantes S.A. from Itafos Inc. (TSXV:IFOS) ) for $14.9 million.

Itafos Inc. Announces Elena Viyella De Paliza Did Not Stand for Re-Election as Director

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Announces Results of Updated Itafos Conda Technical Report

Itafos Inc., Annual General Meeting, Jun 19, 2024

Itafos' (CVE:IFOS) Soft Earnings Are Actually Better Than They Appear

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CEO & Director exercised options to buy CA$84k worth of stock.

Third quarter 2023 earnings released: EPS: US$0.016 (vs US$0.043 in 3Q 2022)

Itafos Inc. Narrows its Earnings Guidance for 2023

Little Excitement Around Itafos Inc.'s (CVE:IFOS) Earnings

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Investor sentiment improves as stock rises 16%

Itafos (CVE:IFOS) Knows How To Allocate Capital Effectively

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Provides Earnings Guidance for the Year 2023

Does Itafos (CVE:IFOS) Have A Healthy Balance Sheet?

Itafos Files Updated Feasibility Study for the Farim Phosphate Project

Itafos Inc. Completes Updated Feasibility Study for the Farim Phosphate Project

Consensus EPS estimates increase by 16%

Itafos Inc., Annual General Meeting, Jul 13, 2023

First quarter 2023 earnings released: EPS: US$0.15 (vs US$0.18 in 1Q 2022)

Itafos Announces Notice to Proceed for Husky 1/North Dry Ridge

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 22%

Is Itafos (CVE:IFOS) Using Too Much Debt?

Investor sentiment improves as stock rises 16%

Consensus EPS estimates fall by 26%

Price target decreased to CA$5.25

Itafos Inc. Provides Earnings Guidance for Fiscal Year 2022

Price target decreased to CA$5.25

Investor sentiment deteriorated over the past week

Is Itafos (CVE:IFOS) Using Too Much Debt?

Investor sentiment improved over the past week

Consensus EPS estimates increase by 17%

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Appoints Matthew O’Neill as Chief Financial Officer Succeeding George Burdette

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Itafos Inc. Announces Production and Sales of Hydrofluorosilicic Acid at Conda

Investor sentiment improved over the past week

Itafos Inc. Provides Earnings Guidance for the First Half and Second Half of 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

These 4 Measures Indicate That Itafos (CVE:IFOS) Is Using Debt Extensively

Less than half of directors are independent

Itafos Inc., Annual General Meeting, Jun 24, 2022

Itafos Inc. Announces Board Changes

Itafos Inc. Announces Resumption of Sulfuric Acid Production at Arraias

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Second quarter 2021 earnings released: EPS US$0.05 (vs US$0.11 loss in 2Q 2020)

Health Check: How Prudently Does Itafos (CVE:IFOS) Use Debt?

First quarter 2021 earnings released: EPS US$0.01 (vs US$0.10 loss in 1Q 2020)

Is Itafos (CVE:IFOS) Using Debt In A Risky Way?

Full year 2020 earnings released: US$0.34 loss per share (vs US$1.02 loss in FY 2019)

This Analyst Just Made A Massive Upgrade To Their Itafos (CVE:IFOS) Earnings Forecasts

Itafos Appoints David Brush as Chief Strategy Officer

Itafos(TSXV:IFOS) dropped from S&P/TSX Venture Composite Index

New 90-day high: CA$0.52

Itafos Announces Notice of Intent for Conda Mine Life Extension

Can You Imagine How Elated Itafos' (CVE:IFOS) Shareholders Feel About Its 743% Share Price Gain?

Itafos Announces Executive Changes